Cancer Screening

Early Detection. Better Outcomes. Ethical Care.

At Central Gastro, we believe that cancer detected early is cancer defeated early. Gastrointestinal, liver, and pancreatic cancers often develop silently, without obvious symptoms until advanced stages. Regular screening helps identify these conditions early, when treatment is most effective and recovery outcomes are significantly improved.

Why Cancer Screening Matters

Detects precancerous growths before they turn malignant
Identifies cancers at an early, treatable stage
Reduces risk of complications and advanced disease
Provides reassurance and peace of mind for high-risk patients

Types of Digestive Cancers We Screen For

1. Esophageal Cancer

Who should screen? Patients with chronic acid reflux, Barrett’s esophagus, or smoking/alcohol history.
Screening methods: Upper GI endoscopy, biopsy, narrow-band imaging.

Know More

2. Stomach (Gastric) Cancer

Who should screen? Individuals with family history, H. pylori infection, or persistent gastritis/ulcers.
Screening methods: Upper GI endoscopy, H. pylori testing, targeted biopsies.

3. Colorectal Cancer

Who should screen? All adults above 45 years, or earlier if family history/polyps present.
Screening methods: Colonoscopy, polypectomy, fecal occult blood test (FOBT), advanced imaging.

Know More

4. Liver Cancer (Hepatocellular Carcinoma – HCC)

Who should screen? Patients with hepatitis B/C, cirrhosis, or fatty liver disease.
Screening methods: Ultrasound, Fibroscan/Elastography, alpha-fetoprotein (AFP) blood test, MRI/CT if needed.

Know More

5. Pancreatic Cancer

Who should screen? High-risk groups – family history, chronic pancreatitis, pancreatic cysts, genetic syndromes.
Screening methods: Endoscopic Ultrasound (EUS), MRI/MRCP, genetic testing in select cases.

Know More

6. Biliary Tract & Gallbladder Cancer

Who should screen? Patients with gallstones, chronic gallbladder inflammation, or abnormal bile duct conditions.
Screening methods: Ultrasound, MRCP, ERCP, EUS-guided biopsy.

Know More

7. Small Intestinal & Rare GI Tumors (e.g., GIST, NETs)

Who should screen? Patients with unexplained bleeding, anemia, or abdominal masses.
Screening methods: Endoscopic Ultrasound (EUS), MRI/MRCP, genetic testing in select cases.

🧪 High-Risk Surveillance Programs

We provide specialized surveillance programs for individuals with:
✔ Family history of GI cancers
✔ Genetic syndromes (e.g., Lynch Syndrome, FAP)
✔ Chronic liver disease or cirrhosis
✔ Barrett’s esophagus or inflammatory bowel disease (IBD)